Cargando…

Evolutionary and Structural Features of the C2, V3 and C3 Envelope Regions Underlying the Differences in HIV-1 and HIV-2 Biology and Infection

BACKGROUND: Unlike in HIV-1 infection, the majority of HIV-2 patients produce broadly reactive neutralizing antibodies, control viral replication and survive as elite controllers. The identification of the molecular, structural and evolutionary footprints underlying these very distinct immunological...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barroso, Helena, Borrego, Pedro, Bártolo, Inês, Marcelino, José Maria, Família, Carlos, Quintas, Alexandre, Taveira, Nuno
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024314/ https://www.ncbi.nlm.nih.gov/pubmed/21283793 http://dx.doi.org/10.1371/journal.pone.0014548

Ejemplares similares

An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates
por: Taveira, Nuno, et al.
Publicado: (2023)

The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients
por: Borrego, Pedro, et al.
Publicado: (2008)

Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response
por: Rocha, Cheila, et al.
Publicado: (2013)

Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals
por: Martin, Francisco, et al.
Publicado: (2022)

Origin and Epidemiological History of HIV-1 CRF14_BG
por: Bártolo, Inês, et al.
Publicado: (2011)

A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies
por: Calado, Rita, et al.
Publicado: (2020)

Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds
por: Moranguinho, Inês, et al.
Publicado: (2023)

Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women
por: Bártolo, Inês, et al.
Publicado: (2018)

Correction: Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women
por: Bártolo, Inês, et al.
Publicado: (2018)

Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients
por: Marcelino, Rute, et al.
Publicado: (2021)

Evolutionary dynamics of HIV-1 subtype C in Brazil
por: Souto, Bernardino, et al.
Publicado: (2021)

Epidemic history of hepatitis C virus genotypes and subtypes in Portugal
por: Palladino, Claudia, et al.
Publicado: (2018)

Computational Modulation of the V3 Region of Glycoprotein gp125 of HIV-2
por: Serra, Patrícia A., et al.
Publicado: (2021)

Unveiling a family of spiro-β-lactams with anti-HIV and antiplasmodial activity via phosphine-catalyzed [3+2] annulation of 6-alkylidene-penicillanates and allenoates
por: Alves, Américo J. S., et al.
Publicado: (2022)

High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients
por: Bártolo, Inês, et al.
Publicado: (2022)

An Evolutionary-Network Model Reveals Stratified Interactions in the V3 Loop of the HIV-1 Envelope
por: Poon, Art F. Y, et al.
Publicado: (2007)

HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola
por: Bártolo, Inês, et al.
Publicado: (2014)

Mapping mutational effects along the evolutionary landscape of HIV envelope
por: Haddox, Hugh K, et al.
Publicado: (2018)

Determinants of Tenascin-C and HIV-1 envelope binding and neutralization
por: Mangan, Riley J., et al.
Publicado: (2019)

P09-04. Charge changes in the alpha2-helix in the C3 region of the HIV-1 subtype C envelope mediate neutralization escape
por: Moore, PL, et al.
Publicado: (2009)

A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support
por: Döring, Matthias, et al.
Publicado: (2016)

Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain
por: Beretta, Maxime, et al.
Publicado: (2020)

Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART
por: Kitawi, Rose C., et al.
Publicado: (2017)

Evolutionary Interactions between N-Linked Glycosylation Sites in the HIV-1 Envelope
por: Poon, Art F. Y, et al.
Publicado: (2007)

Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies
por: Deshpande, Suprit, et al.
Publicado: (2016)

Inhibition of HIV-1 subtype C by 2’F-RNA aptamers isolated against enveloped pseudovirus
por: London, GG, et al.
Publicado: (2012)

Donor-Recipient Identification in Para- and Poly-phyletic Trees Under Alternative HIV-1 Transmission Hypotheses Using Approximate Bayesian Computation
por: Romero-Severson, Ethan O., et al.
Publicado: (2017)

Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion
por: Gallo, Stephen A, et al.
Publicado: (2006)

Chemical Analysis of Gunpowder and Gunshot Residues
por: Serol, Miguel, et al.
Publicado: (2023)

Synonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics
por: Lemey, Philippe, et al.
Publicado: (2007)

The Origin and Evolutionary History of HIV-1 Subtype C in Senegal
por: Jung, Matthieu, et al.
Publicado: (2012)

Evolutionary Dynamics of Tat in HIV-1 Subtypes B and C
por: Roy, Chandra Nath, et al.
Publicado: (2015)

The HIV-1 Envelope Glycoprotein C3/V4 Region Defines a Prevalent Neutralization Epitope following Immunization
por: Lei, Lin, et al.
Publicado: (2019)

Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies
por: Smith, Douglas H., et al.
Publicado: (2010)

Subtle evolutionary changes in the distribution of N-glycosylation sequons in the HIV-1 envelope glycoprotein 120
por: Rao, R. Shyama Prasad, et al.
Publicado: (2010)

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
por: Lacerda, Miguel, et al.
Publicado: (2013)

Prediction of Peptide and Protein Propensity for Amyloid Formation
por: Família, Carlos, et al.
Publicado: (2015)

Differential binding of the HIV-1 envelope to phosphatidylserine receptors
por: Gu, Linlin, et al.
Publicado: (2017)

Evolutionary Genetics of Mycobacterium Tuberculosis and HIV-1: “The Tortoise and the Hare”
por: Santos-Pereira, Ana, et al.
Publicado: (2021)

Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in Mozambique
por: Palladino, Claudia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a4lk31h8c5hue315730onr190u